| Literature DB >> 27483471 |
David C Warhurst1, John C Craig2, K Saki Raheem3.
Abstract
Antimalarial chloroquine (CQ) prevents haematin detoxication when CQ-base concentrates in the acidic digestive vacuole through protonation of its p-aminopyridine (pAP) basic aromatic nitrogen and sidechain diethyl-N. CQ export through the variant vacuolar membrane export channel, PFCRT, causes CQ-resistance in Plasmodium falciparum but 3-methyl CQ (sontochin SC), des-ethyl amodiaquine (DAQ) and bis 4-aminoquinoline piperaquine (PQ) are still active. This is determined by changes in drug accumulation ratios in parasite lipid (LAR) and in vacuolar water (VAR). Higher LAR may facilitate drug binding to and blocking PFCRT and also aid haematin in lipid to bind drug. LAR for CQ is only 8.3; VAR is 143,482. More hydrophobic SC has LAR 143; VAR remains 68,523. Similarly DAQ with a phenol substituent has LAR of 40.8, with VAR 89,366. In PQ, basicity of each pAP is reduced by distal piperazine N, allowing very high LAR of 973,492, retaining VAR of 104,378. In another bis quinoline, dichlorquinazine (DCQ), also active but clinically unsatisfactory, each pAP retains basicity, being insulated by a 2-carbon chain from a proximal nitrogen of the single linking piperazine. While LAR of 15,488 is still high, the lowest estimate of VAR approaches 4.9 million. DCQ may be expected to be very highly lysosomotropic and therefore potentially hepatotoxic. In 11 pAP antimalarials a quadratic relationship between logLAR and logResistance Index (RI) was confirmed, while log (LAR/VAR) vs logRI for 12 was linear. Both might be used to predict the utility of structural modifications.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27483471 PMCID: PMC4970729 DOI: 10.1371/journal.pone.0160091
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Structures of the main pAP compounds examined.
Note outline (blue) of the p-aminopyridine moiety in CQ(2) and its presence in Atebrin, ATB(1) and (5). Also note 2 pAP moieties in each of (3), (4) and (6). Compound (5), a half–piperaquine, has low antiparasitic activity and shows 6 times less activity in the in vitro BIHA test than PQ (3) [14].
Fig 2Structures of the German CQ (resochin) replacement sontochin (SC) and PH-203, a highly active pAP recently developed from SC [20].
Physicochemical and other parameters for the compounds studied.
| antilog | LAR/VAR | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| logD4.8 | logD7.4 | Log CQ RI | logD7.4 | Antilog | D7.4-D4.8 | BHIA | BHIA | BHIA | |||||||||
| Drug | logP | pKa1 | pKa2 | pKa3 | pKa4 | pH | logD | (LAR/VAR) | LOGLAR | (res/sens) | LAR | logD4.8 | VAR | logVAR | IC50 mM | SE | n |
| CQ | 4.72 | 10.18 | 8.38 | -20 | -20 | 7.4 | 0.91668 | 1434882 | 5.156796 | 1.3 | 0.11 | 8 | |||||
| CQ | 4.72 | 10.18 | 8.38 | -20 | -20 | 4.8 | -4.24011 | -4.2401 | 0.91668 | 1.149 | 8.25434 | 5.75E-05 | |||||
| PQ | 6.11 | 6.88 | 6.24 | 5.72 | 5.39 | 7.4 | 5.98833 | 104378.2 | 5.01861 | 0.62 | 0.05 | 6 | |||||
| PQ | 6.11 | 6.88 | 6.24 | 5.72 | 5.39 | 4.8 | 0.96972 | 0.96972 | 5.98833 | 0.39 | 973492 | 9.3266 | |||||
| OHPQ | 5.67 | 6.6 | 6.41 | 5.39 | 4.83 | 7.4 | 5.60001 | 19874.33 | 4.298293 | 0.58 | 0.09 | 6 | |||||
| OHPQ | 5.67 | 6.6 | 6.41 | 5.39 | 4.83 | 4.8 | 1.30172 | 1.30172 | 5.60012 | 0.176 | 398118 | 20.032 | |||||
| DCQ | 6.1 | 8.71 | 8.34 | 7.36 | 5.9 | 7.4 | 4.19 | 48897788 | 6.69 | 0.61 | 0.09 | 7 | |||||
| DCQ | 6.1 | 8.71 | 8.34 | 7.36 | 5.9 | 4.8 | -2.5 | -2.5 | 4.19 | 0.176 | 15488.2 | 0.0032 | |||||
| DCQa | 6.1 | 8.71 | 8.34 | 7.36 | 5.9 | 7.4 | 3.53586 | 3.79E+08 | 8.579145 | 0.61 | 0.09 | 7 | |||||
| DCQa | 6.1 | 8.71 | 8.34 | 7.36 | 5.9 | 4.8 | -5.04328 | -5.0433 | 3.53586 | 0.176 | 3434.48 | 9.05E-06 | |||||
| 5 | 3.48 | 7.92 | 5.54 | -20 | -20 | 7.4 | 2.84081 | 1965.476 | 3.293468 | 3.35 | 0.33 | 9 | |||||
| 5 | 3.48 | 7.92 | 5.54 | -20 | -20 | 4.8 | -0.45266 | -0.4527 | 2.84081 | 1.308 | 693.123 | 0.3526 | |||||
| HCQ | 3.835 | 9.66 | 8.27 | -20 | -20 | 7.4 | 0.64976 | 139607.1 | 5.144907 | ||||||||
| HCQ | 3.835 | 9.66 | 8.27 | -20 | -20 | 4.8 | -4.49515 | -4.4952 | 0.64976 | 1.898 | 4.46437 | 3.20E-05 | |||||
| DECQ | 4.35 | 10.96 | 8.4 | -20 | -20 | 7.4 | -0.2514 | 144113.8 | 5.158706 | ||||||||
| DECQ | 4.35 | 10.96 | 8.4 | -20 | -20 | 4.8 | -5.41011 | -5.4101 | -0.2514 | 1.564 | 0.56053 | 3.89E-06 | |||||
| DAQ | 3.31 | 8.72 | 7.53 | -20 | -20 | 7.4 | 1.61036 | 89365.84 | 4.951172 | ||||||||
| DAQ | 3.31 | 8.72 | 7.53 | -20 | -20 | 4.8 | -3.34081 | -3.3408 | 1.61034 | 0.732 | 40.7721 | 0.0005 | |||||
| AQ | 4.26 | 8.66 | 7.05 | -20 | -20 | 7.4 | 2.82344 | 47410.07 | 4.675871 | ||||||||
| AQ | 4.26 | 8.66 | 7.05 | -20 | -20 | 4.8 | -1.85244 | -1.8524 | 2.82344 | 0.297 | 665.94 | 0.014 | |||||
| ATB | 4.85 | 10.47 | 7.12 | -20 | -20 | 7.4 | 1.59654 | 54779.28 | 4.738616 | ||||||||
| ATB | 4.85 | 10.47 | 7.12 | -20 | -20 | 4.8 | -3.14207 | -3.1421 | 1.59654 | 0.682 | 39,4951 | 0.0007 | |||||
| SC | 5.15 | 10.15 | 7.28 | -20 | -20 | 7.4 | 2.1544 | 68522.82 | 4.835835 | ||||||||
| SC | 5.15 | 10.15 | 7.28 | -20 | -20 | 4.8 | -2.68144 | -2.6814 | 2.1544 | 0.376 | 142.92 | 0.0021 | |||||
| PH203 | 6.45 | 10.29 | 5.57 | -20 | -20 | 7.4 | 3.55307 | 2698.94 | 3.41193 | ||||||||
| PH203 | 6.45 | 10.29 | 5.57 | -20 | -20 | 4.8 | 0.12188 | 0.12188 | 3.55307 | 0.193 | 3573.32 | 1.324 |
Fig 32nd order polynomial for logRI (y) on Log LAR(x) for 11 p-aminopyridines and one outlier.
AM1 energies.
Note reduced distance between N-1 and 4-amino N atoms in all the diprotonated forms and increased separation of quinolines N1 in tetraprotonated forms of DCQ.
| AMI (rms 0.001) | R&S | R&S | R&S | PQ | PQ2H+ | PQ4+ | R-DCQ,S- | R-DCQ,S- | R-DCQ,S- | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CQ | CQ1H+ | CQ2H+ | (N-1) | DCQ | DCQ (2H+) | DCQ (4H+) | RS-DCQ | RS-DCQ N1-2H+ | RS-DCQ 4H+ | |||
| Total energy kcal/mol | -84345 | -84513 | -84650 | -141613 | -141941 | -142025 | -138676 | -139012 | -139065 | -138675 | -139010 | -139071 |
| HOF kcal/mol | 23.65 | 170.2 | 347.9 | 126.7 | 428.8 | 974 | 106.2 | 400.7 | 977.4 | 107.9 | 402.1 | 971.3 |
| distance between quinolines N-1 | NA | NA | NA | 17.65Å | 18.29Å | 18.3Å | 15.01Å | 16.43Å | 11.93Å | 15.99Å | ||
| bridging sc N-N | NA | NA | NA | 4.985Å | 4.965Å | 5.073Å | 2.986Å | 2.985Å | 3.036Å | 2.952Å | 2.983Å | 3.019Å |
| quinoline N-1 | 7.893Å | 7.999Å | 8.991Å | 6.526Å | 6.827Å | 6.83Å | 6.038Å | 6.992Å | 7.0Å | 7.585Å | 6.806Å | 7.662Å |
| to terminal sc-N | 6.52Å | 6.819Å | 6.837Å | 6.582Å | 6.836Å | 7.032Å | 6.774Å | 7.534Å | 7.571Å | |||
| separation of N-1 | 4.255 Å | 4.258 Å | 4.280 | 4.231 | 4.282 | 4.234 | 4.260 | 4.221 | ||||
| and 4-amino N | 4.280 | 4.231 | 4.252 | 4.222 | 4.249 | 4.210 |